RHYTHM PHARMACEUTICALS, INC.

RYTM · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $6.3B · 414 employees
164
SEC Filings
$89.47
Close 2026-10-26
414
Employees

Business Summary

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on rare neuroendocrine diseases. Its lead product, IMCIVREE (setmelanotide), is an MC4R agonist approved in the U.S., EU, UK, Canada, and other countries for treating obesity caused by Bardet-Biedl syndrome and certain genetic MC4R pathway deficiencies. The company also develops two investigational MC4R agonists: bivamelagon (oral) and RM-718 (weekly subcutaneous), targeting hypothalamic obesity, Prader-Willi syndrome, and rare genetic MC4R pathway diseases.

Latest Stock Quote

RYTM 2026-10-26 $89.47 O:$90.07 H:$90.81 L:$89 Vol:0.3M VWAP:$89.6497
origin leaf: null

Next Earnings

expected 2027-02-02

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012399EDGAR118K words
2025-02-282024-12-310001558370-25-001889EDGAR122K words
2024-02-292023-12-310001558370-24-002181EDGAR115K words
2023-03-012022-12-310001558370-23-002613EDGAR109K words
2022-03-012021-12-310001558370-22-002543EDGAR105K words
2021-03-012020-12-310001558370-21-002121EDGAR98K words
2020-03-022019-12-310001558370-20-001896EDGAR116K words
2019-03-082018-12-310001558370-19-001698EDGAR118K words
2018-03-122017-12-310001558370-18-001923EDGAR104K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-032026-09-300001628280-26-069485EDGAR71K words
2026-08-042026-06-300001628280-26-052533EDGAR70K words
2025-11-042025-09-300001104659-25-106264EDGAR74K words
2025-08-052025-06-300001558370-25-010302EDGAR73K words
2025-05-072025-03-310001558370-25-006765EDGAR70K words
2024-11-062024-09-300001558370-24-014532EDGAR73K words
2024-08-062024-06-300001558370-24-011101EDGAR72K words
2024-05-072024-03-310001558370-24-007076EDGAR69K words
2023-11-082023-09-300001558370-23-018291EDGAR66K words
2023-08-012023-06-300001558370-23-012739EDGAR66K words
2023-05-022023-03-310001558370-23-007675EDGAR63K words
2022-11-082022-09-300001558370-22-016818EDGAR66K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-030001628280-26-069106EDGAR5K words
2026-08-040001628280-26-052170EDGAR5K words
2026-04-030001628280-26-023606EDGAR1K words
2026-03-260001628280-26-021414EDGAR1K words
2026-03-200001628280-26-019995EDGAR2K words
2026-03-160001628280-26-018211EDGAR2K words
2026-03-020001104659-26-021801EDGAR2K words
2026-02-260001628280-26-011987EDGAR5K words
2026-01-090001628280-26-001459EDGAR6K words
2025-12-190001104659-25-123108EDGAR0K words

164 total filings indexed. 133 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

rare-neuroendocrine-diseases hypothalamic-obesity bardet-biedl-syndrome prader-willi-syndrome rare-genetic-mc4r-pathway-diseases congenital-hyperinsulinism

Company Identity

CIK0001649904
TickerRYTM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.rhythmtx.com
Listed2017-10-05

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 8d53b93508b84031b123ee622c88b0e7f7a727a2a8997d851b37204ee57335b4
parent: 1283d79045971f1f13bef4c5e1e099a2f3a29a50ae01b913dc68e8cfe412687f
content hash: c385922c6550e5d27c2635b3335a5b38167f5cdc2f1066849950bd7168563914
signed: 2026-11-16T19:04:35.934Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up RYTM using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on RYTM, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/RYTM (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.